Potential Price Increase for Standard BioTools Inc (LAB) After Recent Insider Activity

Standard BioTools Inc’s filing revealed that its Chief Financial Officer Kim Hanjoon Alex unloaded Company’s shares for reported $1344.0 on May 23 ’25. In the deal valued at $0.94 per share,1,428 shares were sold. As a result of this transaction, Kim Hanjoon Alex now holds 930,286 shares worth roughly $0.98 million.

Then, Mackay Sean sold 13,217 shares, generating $12,437 in total proceeds. Upon selling the shares at $0.94, the SVP & Chief Business Officer now owns 843,076 shares.

Before that, Egholm Michael sold 5,473 shares. Standard BioTools Inc shares valued at $5,150 were divested by the President & CEO at a price of $0.94 per share. As a result of the transaction, Egholm Michael now holds 2,741,191 shares, worth roughly $2.88 million.

KeyBanc Capital Markets downgraded its Standard BioTools Inc [LAB] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. Jefferies began covering LAB with “Buy” recommendation on April 04, 2024. KeyBanc Capital Markets started covering the stock on July 12, 2023. It rated LAB as “an Overweight”.

Price Performance Review of LAB

On Friday, Standard BioTools Inc [NASDAQ:LAB] saw its stock unchanged to $1.05. Over the last five days, the stock has lost -0.94%. Standard BioTools Inc shares have fallen nearly -40.00% since the year began. Nevertheless, the stocks have fallen -55.51% over the past one year. While a 52-week high of $2.41 was reached on 01/15/25, a 52-week low of $0.92 was recorded on 05/23/25.

Levels Of Support And Resistance For LAB Stock

The 24-hour chart illustrates a support level at 1.0200, which if violated will result in even more drops to 0.9900. On the upside, there is a resistance level at 1.0900. A further resistance level may holdings at 1.1300.

How much short interest is there in Standard BioTools Inc?

A steep rise in short interest was recorded in Standard BioTools Inc stocks on 2025-05-30, dropping by -1.4 million shares to a total of 17.04 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 18.44 million shares. There was a decline of -8.2%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.